Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment
An Open-Label, Randomized, Parallel Group Study to Investigate the Influence of Renal Impairment on the Efficacy and Safety of Two Doses of Bludigo™ When Used as an Aid in the Determination of Ureteral Patency
Sponsor: Prove pharm
A PHASE4 clinical study on Ureter Injury, this trial is actively recruiting participants. The trial is conducted by Prove pharm and has accumulated 6 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE4
-
Mar 2025 — Feb 2026 [monthly]
Recruiting PHASE4
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Nov 2023 — Feb 2024 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Prove pharm
For direct contact, visit the study record on ClinicalTrials.gov .